tiprankstipranks
Rhythm Biosciences Expands with Genetype Acquisition
Company Announcements

Rhythm Biosciences Expands with Genetype Acquisition

Rhythm Biosciences Ltd. (AU:RHY) has released an update.

Don't Miss Our Christmas Offers:

Rhythm Biosciences Ltd has acquired the Genetype genetic risk assessment business assets, enhancing its oncology portfolio and offering immediate revenue opportunities. This strategic move is expected to diversify Rhythm’s capabilities and accelerate growth by leveraging Genetype’s existing customer base and skilled workforce in Australia and the USA. The integration of Genetype’s proteomic and genomic technologies promises to expand Rhythm’s market reach and boost shareholder returns.

For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App